Stock SOHO PT SOHO GLOBAL HEALTH TBK
Add to a list
To use this feature you must be a member
Log inSign up

Financials PT Soho Global Health Tbk

Equities

SOHO

ID1000157506

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
494 IDR +0.41% Intraday chart for PT Soho Global Health Tbk +0.41% -1.20%
Mar. 27 PT Soho Global Health Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PT Soho Global Health Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 5,838,174 8,090,948 6,885,238 6,345,841
Enterprise Value (EV) 1 4,965,993 7,161,800 5,779,432 5,677,322
P/E ratio 24.1 x 14.7 x 19.3 x 17.1 x
Yield 5.13% 3.09% 4.35% -
Capitalization / Revenue 0.95 x 1.14 x 0.94 x 0.77 x
EV / Revenue 0.81 x 1.01 x 0.79 x 0.69 x
EV / EBITDA 18 x 10.4 x 11.8 x 11.7 x
EV / FCF 19.8 x 17.4 x 31.5 x -47.8 x
FCF Yield 5.05% 5.74% 3.18% -2.09%
Price to Book 2.65 x 3.66 x 2.84 x 2.65 x
Nbr of stocks (in thousands) 12,691,682 12,691,682 12,691,682 12,691,682
Reference price 2 460.0 637.5 542.5 500.0
Announcement Date 3/30/21 3/31/22 3/30/23 3/27/24
1IDR in Million2IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 4,563,185 5,048,301 6,163,939 7,076,164 7,290,121 8,197,755
EBITDA 1 161,361 261,762 275,815 687,921 487,952 484,610
EBIT 1 123,026 226,537 239,893 651,816 443,583 439,339
Operating Margin 2.7% 4.49% 3.89% 9.21% 6.08% 5.36%
Earnings before Tax (EBT) 1 90,449 192,549 249,674 691,157 455,637 463,396
Net income 1 49,392 118,457 172,108 550,176 356,728 371,341
Net margin 1.08% 2.35% 2.79% 7.78% 4.89% 4.53%
EPS 2 6.899 15.29 19.12 43.35 28.11 29.26
Free Cash Flow 1 -37,083 207,580 250,974 410,891 183,532 -118,863
FCF margin -0.81% 4.11% 4.07% 5.81% 2.52% -1.45%
FCF Conversion (EBITDA) - 79.3% 90.99% 59.73% 37.61% -
FCF Conversion (Net income) - 175.24% 145.82% 74.68% 51.45% -
Dividend per Share - - 23.60 19.70 23.60 -
Announcement Date 9/2/20 9/2/20 3/30/21 3/31/22 3/30/23 3/27/24
1IDR in Million2IDR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 207,626 251,157 - - - -
Net Cash position 1 - - 872,181 929,148 1,105,806 668,519
Leverage (Debt/EBITDA) 1.287 x 0.9595 x - - - -
Free Cash Flow 1 -37,083 207,580 250,974 410,891 183,532 -118,863
ROE (net income / shareholders' equity) 4.19% 9.42% 9.78% 25% 15.4% 15.4%
ROA (Net income/ Total Assets) 2.79% 4.67% 4.03% 9.93% 6.53% 5.96%
Assets 1 1,770,449 2,534,382 4,275,550 5,538,536 5,466,342 6,235,471
Book Value Per Share 2 168.0 12,361,480 174.0 174.0 191.0 189.0
Cash Flow per Share 2 38.30 2,477,701 71.20 75.10 88.80 54.20
Capex 1 19,810 28,903 34,153 29,404 33,390 38,751
Capex / Sales 0.43% 0.57% 0.55% 0.42% 0.46% 0.47%
Announcement Date 9/2/20 9/2/20 3/30/21 3/31/22 3/30/23 3/27/24
1IDR in Million2IDR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PT SOHO GLOBAL HEALTH TBK Stock PT Soho Global Health Tbk
-1.20% 386M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.84% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.85% 231B
NOVARTIS AG Stock Novartis AG
+5.23% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-8.75% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SOHO Stock
  4. Financials PT Soho Global Health Tbk